Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study

被引：0
|
作者：
Shoko Marshall
Takeru Wakatsuki
Daisuke Takahari
Tomohiro Matsushima
Naoki Ishizuka
Izuma Nakayama
Hiroki Osumi
Mariko Ogura
Takashi Ichimura
Eiji Shinozaki
Keisho Chin
Kensei Yamaguchi
机构：
[1] Tokyo Women’s Medical University Medical Center East,Department of Medicine
[2] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gastrointestinal Oncology
[3] Saitama Cancer Center,Department of Gastroenterology
[4] Department of Clinical Trial Planning and Management,undefined
[5] Clinical Research & Medical Development Center,undefined
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
HER2; Gastric cancer; Trastuzumab; Prognostic factor; Visceral metastasis; Low hemoglobin; High LDH; High CRP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 484
页数：9
相关论文
共 50 条
  • [31] Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer
    Lemos, L. G. T.
    Victorino, V. J.
    Herrera, A. C. S. A.
    Aranome, A. M. F.
    Cecchini, A. L.
    Simao, A. N. C.
    Panis, C.
    Cecchini, R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (01) : 8 - 14
  • [32] Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
    Kim, Tae-Hwan
    Do Cho, Hun
    Choi, Yong Won
    Lee, Hyun Woo
    Kang, Seok Yun
    Jeong, Geum Sook
    Choi, Jin-Hyuk
    Ahn, Mi Sun
    Sheen, Seung-Soo
    BMC CANCER, 2021, 21 (01)
  • [33] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 361 - 371
  • [34] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2016, 158 : 361 - 371
  • [35] Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
    Shitara, Kohei
    Bang, Yung-Jue
    Iwasa, Satoru
    Sugimoto, Naotoshi
    Ryu, Min-Hee
    Sakai, Daisuke
    Chung, Hyun-Cheol
    Kawakami, Hisato
    Yabusaki, Hiroshi
    Lee, Jeeyun
    Saito, Kaku
    Kawaguchi, Yoshinori
    Kamio, Takahiro
    Kojima, Akihito
    Sugihara, Masahiro
    Yamaguchi, Kensei
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25): : 2419 - 2430
  • [36] Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
    Park, Ji Soo
    Youn, Jong-Chan
    Shim, Chi Young
    Hong, Geu-Ru
    Lee, Choong-Kun
    Kim, Jee Hyung
    Park, Hyung Soon
    Heo, Su Jin
    Beom, Seung Hoon
    Kim, Hyo Song
    Rha, Sun Young
    Chung, Hyun Cheol
    Kang, Seok-Min
    Jung, Minkyu
    ONCOTARGET, 2017, 8 (37) : 61837 - 61845
  • [37] Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer
    Dogan, Izzet
    Karabulut, Senem
    Tastekin, Didem
    Ferhatoglu, Ferhat
    Paksoy, Nail
    Sakar, Burak
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (08): : 1014 - 1019
  • [38] The use of trastuzumab in Japanese patients with HER2-positive advanced or metastatic gastric cancer
    Sawaki, A.
    Ohashi, Y.
    Omuro, Y.
    Satoh, T.
    Hamamoto, Y.
    Boku, N.
    Miyata, Y.
    Takiuchi, H.
    Ohtsu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [39] Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report
    Nagata, Hiromi
    Tsujimoto, Hironori
    Yaguchi, Yoshihisa
    Kouzu, Keita
    Itazaki, Yujiro
    Ishibashi, Yusuke
    Tsuchiya, Satoshi
    Sugihara, Takao
    Ito, Nozomi
    Harada, Manabu
    Nomura, Shinsuke
    Utsumi, Yoshitaka
    Shimazaki, Hideyuki
    Kishi, Yoji
    Ueno, Hideki
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [40] Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC)
    Chen, Shang-Chiung
    Kagedal, Matts
    Gao, Yuying
    Wang, Bei
    Harle-Yge, Marie-Laurence
    Girish, Sandhya
    Jin, Jin
    Li, Chunze
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1147 - 1159
12345